Life Technologies Corporation

CARLSBAD, Calif., May 14, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that Ion PGM(TM) now significantly outperforms its competitor on the major performance metrics for benchtop sequencing. It offers the simplest and fastest workflow, lowest cost-per-sample, and highest sensitivity for multiple basic and ... read more

CARLSBAD, Calif., May 13, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today the issuance of a new patent covering nucleic acids encoding Transcription Activator-Like Effector Nuclease fusion proteins (TALENS) and the formal launch of an associated sublicensing program. The technology has broad utility in ... read more

CARLSBAD, Calif., May 2, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced results for its first quarter ended March 31, 2013. Revenue for the first quarter was $963 million, an increase of 2.5 percent over the $939 million reported for the first quarter of 2012. Excluding ... read more

CARLSBAD, Calif., April 26, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems® 7500 Fast Dx Real-Time PCR instrument is the sole platform cleared for use under the Centers for Disease Control and Prevention (CDC) protocol created for emergency screenings of patients suspected of harbouring ... read more

CARLSBAD, Calif., April 18, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today that it is partnering with Ridom GmbH (Munster, Germany) to make SeqSphere(+) whole genome bacterial typing software available for Ion Torrent users. This software enables any lab to perform fast, affordable, and automated high-resolution bacterial typing ... read more

CARLSBAD, Calif., April 12, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of KDR Biotech Co., Ltd., (KDR Biotech) a leading reagents distributor based in Seoul, Korea. KDR Biotech has been Life's primary reagent distributor in Korea since 1982. The Korean biotechnology market ... read more

CARLSBAD, Calif., April 11, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the launch of Vector NTI® Express Designer, the latest advancement in its Vector NTI® software platform, which offers researchers comprehensive and streamlined custom vector and genetic construct design and synthesis. The desktop ... read more

CARLSBAD, Calif., April 4, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today the introduction of two bioinformatics offerings - Oncomine(R) Gene Browser and Ion Reporter(TM) Oncomine(R) Workflow - that will allow cancer researchers new avenues of access to one of the largest genomics ... read more

CARLSBAD, Calif., April 2, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it launched two Ion AmpliSeq(TM) Community Panels: the Ion AmpliSeq(TM) BRCA1 and BRCA2 Panel design and the Ion AmpliSeq(TM) Colon and Lung Cancer Panel design. The BRCA panel analyzes the coding regions of the tumor suppressor genes ... read more

CARLSBAD, Calif., March 28, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announces plans to invest $18 million in a multi-phase plan to expand its facility in Pleasanton, Calif., where it will implement Current Good Manufacturing Practice (cGMP) capabilities for its genetic analysis products. The ... read more

CARLSBAD, Calif., March 4, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today that it has signed a collaborative research agreement and related license with Harvard University under which it has acquired exclusive rights to develop a panel of characterization assays designed to rapidly evaluate ... read more

CARLSBAD, Calif., Feb. 21, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that the new Center for Personalized Medicine (CPM) at Roswell Park Cancer Institute (RPCI) has purchased four Ion Proton(TM) sequencers and two Ion Personal Genome Machine(TM) (PGM(TM)) sequencers. Founded in 1898, Roswell Park Cancer ... read more

CARLSBAD, Calif., Feb. 21, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will present at Barclays Global Healthcare Conference on March 13 at 11:15 a.m. ET. Ron A. Andrews, Life Technologies' President of Medical Sciences, will present on behalf of the company. The company ... read more

CARLSBAD, Calif., Feb. 11, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. The development represents additional execution against the company's strategy ... read more

CARLSBAD, Calif., Feb. 4, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced results for its fourth quarter for the year ended Dec. 31, 2012. Non-GAAP revenue for the fourth quarter was $999 million, an increase of 3 percent over the $970 million reported for the fourth quarter of ... read more

CARLSBAD, Calif., Jan. 25, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will present at Leerink Swann Global Healthcare Conference on Wednesday, Feb. 13 at 2:00 p.m. ET. Ron A. Andrews, Life Technologies' President of Medical Sciences, will present on behalf of the company. ... read more

CARLSBAD, Calif., Jan. 23, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today it is #33 among the "Global 100 Most Sustainable Corporations." The Global 100 2013 list was announced at the World Economic Forum in Davos, Switzerland earlier today. The goal of the Global ... read more

CARLSBAD, Calif., Jan. 22, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced its acquisition of BAC BV, a privately held company based in the Netherlands, and a leader in the discovery, development and manufacture of protein purification products. The acquisition expands Life's capabilities and ... read more

CARLSBAD, Calif., Jan. 17, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will report its fourth quarter and fiscal year 2012 financial results on Monday, Feb. 4 after market close. (Photo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO) Life Technologies' executives will conduct a webcast on the same day at ... read more

CARLSBAD, Calif., Dec. 18, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will present at JP Morgan 2013 Healthcare Conference on Tuesday, Jan. 8 at 1:30 p.m. PT. Gregory T. Lucier, Life Technologies' Chairman and Chief Executive Officer, will present on behalf of the ... read more